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An effort was made to formulate transdermal patches of Glipizide which is a 
potent antidiabetic drug by using different ratio of polymers like hydroxy propyl methyl 
cellulose, ethyl cellulose and Eudragit. Eight batches of transdermal patches were 
prepared by solvent casting technique in which the best formulation was found out. The 
polymers such as HPMC, Ethyl cellulose, Eudragit were incorporated with Glipizide in 
various proportions, out of which the best formulation on the ratio (HPMC: EC: Eudragit 
- 2:2:1) with the drug was determined. The prepared transdermal patches were uniform in 
shape and white in color which was calculated for physicochemical characteristics, in-
vitro release profile, and in-vivo evaluation on mice. Higuchis plot studies revealed that 
the predominant mechanism of drug release was diffusion. 
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Substantial efforts have been focused 
on the development of new drug delivery 
system. Transdermal dosage form create new 
dimension in the era of controlled drug 
delivery system. Transdermal drug delivery 
systems are designed to achieve a prolonged 
therapeutic effect by continuously releasing 
medication over an extended period of time 
after administration of single dose (Jain 2003). 
Transdermal drug delivery systems have an 
advantage of targeting, reliability, ease of 
administration. Glipizide is an effective oral 
antidiabetic drug. Single dose produced 
provoke a brisk release of insulin from 
pancreases by acting on the so called sulfoxyl 
urea receptors on the pancreatic Beta-cell 
membrane (AlSaidan 2004). The aim was to 
study the polymeric effect on Transdermal 
films of Glipizide with the following 
objectives (Florance 1994). To reduce 
frequency of administration. To avoid first pas 
metabolism. To reduce dose of Glipizide. To 
reduce the oral side effects of Glipizide. The 
molecular weight of drug is 445.5 and the 
melting point (208°c) and its Bioavailability 
through skin (85 to 90%), protein binding (90%) 
were the various important criteria which 
should be considered Glipizide for Transdermal 
drug delivery systems (Rim 2005). The drug 
input can be terminated simply by removing 
the patch. 
 
Materials and Methods 
 The present work was carried out to 
prepare and evaluate transdermal patches of 
Glipizide. It was carried out as follows. Casting 
of plain transdermal patches (Riciere 2001). 
Preparation of drug incorporated polymeric 
films. Physicochemical evaluation of 
transdermal patches. Percentage moisture 
absorption, percentage moisture loss, swelling 
index, time taken for swelling, water vapors 
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transmissions rate, thickness, weight 
uniformity, folding endurance (Cevc 2003). 
In-vitro diffusion studies of transdermal 
patches. In-vitro studies on animals. 
 
Standard curve for Glipizide 
Primary stock solution: - Glipizide 
of 100mg was accurately weighed and 
dissolved in water to obtain 100ml of 
solution with a concentration of 
l000mcg/ml. 
Secondary stock solution: - 1ml of primary 
stock solution was diluted to 100ml with 
water to get a concentration of 10mcg/ml 
from the secondary stock solution Aliquots 
ranging from 1ml to 8ml were pipette out 
and dilute to 10ml with water to get the 
concentration range of 1mcg/ml to 
8mcg/ml. The absorbance were measured 
at 269nm. 
 
Standard curve value for Glipizide 
Concentration  
(mcg/ml) Absorbance 
1 0.002 
2 0.010 
3 0.014 
4 0.020 
5 0.026 
6 0.032 
7 0.034 
8 0.036 
 
Solvent casting technique  
The films were prepared by the 
method of solvent casting technique 
(Merkle 1989). Fabrication of drug reservoir 
films with hydroxy propyl methyl cellulose, 
Ethyl cellulose and Eudragit. Accurately 
weighed quantity of hydroxy propyl 
methyl cellulose, hydroxyl ethyl cellulose 
and Eudragit of composition of different 
formulations get mixed with 10mg of 
Glipizide (Vavrova 2005). Then add 2.5ml 
of distilled water. Then it was poured over 
the mercury surface in a petridish and 
allowed to dry at room temperature (Nicoli 
2001). The same procedure was repated 
with different composition of polymers 
with Glipizide. 
 
PHYSICO-CHEMICAL EVALUATION 
Percent moisture absorption 
 The percent moisture absorption 
test was carried out to check the physical 
stability of the transdermal films at high 
humid conditions. In the present study the 
moisture absorption capacity of the films 
were determined as follows. Three 1.00cm 
diameter films were cut out and weighed 
accurately then the films were placed in 
dessicator containing saturated solution of 
aluminum chloride keeping the humidity 
inside the dessicator at 79.5% after 3 days 
the films were removed ./weighed and 
percentage moisture was calculated . 
Average percentage moisture absorption of 
three films was found. 
 
Percentage moisture loss 
 This test was also carried to check 
the integrity of films at dry condition. Three 
l.cm diameter films were cut out and 
weighed accurately and kept in a dessicator 
containing fused anhydrous calcium 
chloride. After 72 hours the films were 
removed and weighed. Average percentage 
moisture losses of three films were found 
out. Percentage moisture loss= [(initial 
weight -final weight)] /initial weight)*100. 
 
Swelling index 
 Three films are taken from each 
batch and it is put in pH6.6 phosphate 
buffer and the weight in moisture every 
three minutes till the weight becomes 
constant. 
 
Water vapour transmission rate 
 For water vapour transmission 
rate glass vials of equal diameter were used 
as transmission cells. These transmission 
cells were washed thoroughly dried in an 
oven. About 1 gm of anhydrous calcium 
chloride was taken in the cells and the 
polymer films were fixed over the brim 
with the help of the solvent. The cells were 
accurately weighed. Then allow to Kept in 
a closed desecrator containing saturated 
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solution of potassium chloride to maintain 
humidity of 84% RH. The cells taken 
weighed after 6,12, 24,36,48,72 hours of 
storage. The amount of water vapour 
transmitted were found out using the 
formula. 
 
Water vapour transmission rate = Final weight-Initial weight 
                                                  Time x area 
Water vapour transmission rate usually expressed as the number of grams of moisture/hr/sq.cm. 
from the data obtained water vapour transmission calculated. 
 
Thickness 
 Thickness of the film was 
measured at six different points using a 
screw guage and average thicknesses of 
three films were found out. 
 
Weight of film 
Each film was weighed individually and 
average weight of three films were found 
out. 
 
Folding endurance 
It was determined by repeatedly folding a 
small strip of films at the same place till it 
broke. The number of times, the films could 
be folded at the same place without 
breaking gave the value of folding 
endurance. 
 
Drug content 
A film size of 1 cm diameter was cut and 
dissolved in phosphate buffer. After adding 
suitable reagent and dilution, optical 
density was found out at 269 nm. Average 
during content of three transdermal, films 
were determined. 
 
In-vitro drug release evaluation 
Here, dissolution test apparatus USP 
(paddle type) was employed throughout 
the study. The medium employed was 0.1N 
HCL at 37°C room temperature. The 
dissolution was carried out at an RPM 
maintained was at 100 with in a stipulated 
interval ofl5min. A film of size diameter 
was cut and introduced in to the cylinder 
filled with equal quantity of 0.1N HCL as 
the medium. Sample of 10ml were 
withdrawn at every 15min duration for 
continues two hours. The volumes of 
sample withdrawn were replaced by the 
same volume of dissolution medium. Filter 
the above sample and then taken 5ml from 
each sample and made at 50ml with the 
medium. The withdrawn samples were 
analyzed by using visible UV 
spectrophotometer 269nm using reagent 
blank (Brown 1998). 
 
In-vivo studies 
Acute and long term hypoglycemic activity, 
biochemical and histopathologic studies, 
skin irritation and pharmacokinetic studies 
in mice (Carmichael 1994). 
 
Skin Irritation test (Visual and 
histopathological evalution of skin 
(Benowitz 1992)) 
The mice were divided into 5- groups (n=6) 
on the previous day of the experiment the 
hair on the back side area of mice was 
removed. The animals of group I was 
served as normal, without any treatment. 
One group of animals (group II, control) 
was applied with marketed adhesive type 
(official adhesive type in USP). 
Transdermal system (blank, without drug 
and drug loaded) were applied into nude 
skin of animals of 3 and 4 groups AO.8% 
v/v aqueous solution of formation was 
applied as a standard irritant (Group V) 
(Prausnitz 2004). The formation solution 
each day upto 7 days and finally the 
application sites were graded according to 
a visual scoring scale, always by the same 
investigator. 
The erythema scale was as follows:- 
0, none; 1, slight; 2, well defined; 3, moderate; 
and 4, scar formation. The edema scale was; 0, 
none; 1, slight; 2, well defined; 3, moderate; and 
4, severe. After visual evaluation of skin 
irritation the animals were sacrificed and skin 
samples were processed for histological 
examination (6) 
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Results and Discussion 
In the present study, the transdermal patches 
of Glipizide were prepared by using different 
polymers such as hydroxy propyl methyl 
cellulose K100m, Ethyl cellulose and Eudragit 
L100 by solvent casting method. Invitro 
dissolution study of drug along with different 
combination of polymers that is hydroxy propyl 
methyl cellulose, Ethyl cellulose, Eudrgit has 
been preformed. The higher rate and 
percentage of release of drug in film containing 
less concentrations of Eudragit i.e., in batch B4 
(HPMC: Ethyl cellulose: Eudragit (2:2:l) has 
been performed.  As the percentage of 
Eudragit was reduced the rate of release of drug 
was increased. Hence moreover, the batch 
shows the best moisture of films and the graph 
representing the best sustained drug release. 
Film with batch code B4 shows better stability 
and suitability. 
 
Composition of polymers with drug 
Batch 
Code 
Polymers Solvent 
Plasticize
r 
HPMC 
K100M
% 
EC% 
EUDR
AGIT  
L 
100% 
Aceton
e 
ml 
Glycerin 
(%W/W) 
B1 1 1 1 2.5 30  
B2 2 1 1 2.5 30 
B3 1 2 1 2.5 30 
B4 2 2 1 2.5 30 
B5 1 1 2 2.5 30 
 
In-vitro drug release for batch 1 -5 
Time 
Square 
root of 
time 
Cumulative drug release (%) 
Batch 1 Batch 2 Batch 3 Batch 4 Batch 5 
5 2.236 9.48 13.55 16.8 24.2 17.71 
10 3.162 15.95 18.97 24.52 33.18 19.53 
15 3.873 22.84 24.84 32.25 45.66 25.88 
20 4.472 29.74 35.68 37.69 57.77 37.24 
25 5 32.33 39.747 44.51 64.29 44.05 
30 5.477 33.62 42.006 50.41 73.6 49.5 
 
Conclusion 
The formulation containing 2 parts of HPMC, 2 
parts of Ethyl cellulose and 1 part of Eudragit, 
has shown best release in concentration 
independent manner. Higuchi's plot revealed 
that predominant mechanism of drug release 
in diffusion. Hence the formulation achieved 
the objectives of present study such as reducing 
the dose, improving bio-availability by avoiding 
first pass metabolism and it may have better 
patient compliance. 
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